Axsome Therapeutics, Inc. Share Price: AXSM (Axsome Therapeutics, Inc.) Stock Price Today & Updates | INDmoney

Question 1

What is Axsome Therapeutics, Inc. share price today?

Accepted Answer

Axsome Therapeutics, Inc. (AXSM) share price today is {{live_price}}.

Question 2

Can Indians buy Axsome Therapeutics, Inc. shares?

Accepted Answer

Yes, Indians can invest in the Axsome Therapeutics, Inc. (AXSM) from India.

With INDmoney, you can buy Axsome Therapeutics, Inc. at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Axsome Therapeutics, Inc. at zero transaction cost.

Question 3

How can I buy Axsome Therapeutics, Inc. shares from India?

Accepted Answer

It is very easy to buy Axsome Therapeutics, Inc. from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Question 4

Can Fractional shares of Axsome Therapeutics, Inc. be purchased?

Accepted Answer

Yes, you can buy fractional shares of Axsome Therapeutics, Inc. with INDmoney app.

Question 5

What are the documents required to start investing in Axsome Therapeutics, Inc. stocks?

Accepted Answer

To start investing in Axsome Therapeutics, Inc., You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

Question 6

What are today’s High and Low prices of Axsome Therapeutics, Inc.

Accepted Answer

Today’s highest price of Axsome Therapeutics, Inc. (AXSM) is {{1_rba_end}}.

Today’s lowest price of Axsome Therapeutics, Inc. (AXSM) is {{1_rba_st}}.

Question 7

What is today's market capitalisation of Axsome Therapeutics, Inc.

Accepted Answer

Today's market capitalisation of Axsome Therapeutics, Inc. AXSM is 4.1B

Question 8

What is the 52 Week High and Low Range of Axsome Therapeutics, Inc.

Accepted Answer

52 Week High
{{rba_end}}
52 Week Low
{{rba_st}}

Question 9

How much percentage Axsome Therapeutics, Inc. is down from its 52 Week High?

Accepted Answer

Axsome Therapeutics, Inc. (AXSM) share price is {{live_price}}. It is down by {{w52lu}}% from its 52 Week High price of {{rba_end}}.

Question 10

How much percentage Axsome Therapeutics, Inc. is up from its 52 Week low?

Accepted Answer

Axsome Therapeutics, Inc. (AXSM) share price is {{live_price}}. It is up by {{w52hd}}% from its 52 Week Low price of {{rba_st}}.

Question 11

What are the historical returns of Axsome Therapeutics, Inc.?

Accepted Answer

1 Month Returns
{{1mr}}%
3 Months Returns
{{3mr}}%
1 Year Returns
{{1yr}}%
5 Years Returns
{{5yr}}%

Question 12

Who is the Chief Executive Officer (CEO) of Axsome Therapeutics, Inc.

Accepted Answer

Dr. Herriot  Tabuteau M.D. is the current Chief Executive Officer (CEO) of Axsome Therapeutics, Inc..

Period	Axsome Therapeutics, Inc.	Sector (Health Care)	Index (Russel 2000)
3 Months	19.9%	6.5%	0.0%
6 Months	-4.3%	7.1%	0.0%
1 Year	12.83%	9.8%	0.0%
3 Years	66.02%	14.2%	-20.2%

Market Capitalization	4.1B
Book Value	$3.04
Earnings Per Share (EPS)	-6.45
PEG Ratio	0.0
Wall Street Target Price	125.06

Profit Margin	-118.07%
Operating Margin TTM	-91.58%

Return On Assets TTM	-32.76%
Return On Equity TTM	-231.68%

Revenue TTM	251.0M
Revenue Per Share TTM	5.41
Quarterly Revenue Growth YOY	-20.7%
Gross Profit TTM	45.9M
EBITDA	-244.5M
Diluted Eps TTM	-6.45
Quarterly Earnings Growth YOY	0.0

Axsome Therapeutics, Inc. (AXSM)

Performance

Returns

Highlights

Analyst Recommendation

Analyst Forecast

Technicals Summary

Peers

Increasing Revenue

Increasing Net Profit

Vs NVO

Vs NVO

Institutional Holdings

Corporate Announcements

Axsome Therapeutics, Inc. Earnings

Company Information

Discover More

FAQs

EPS Estimate Current Year	-4.75
EPS Estimate Next Year	-0.44
EPS Estimate Current Quarter	-1.2
EPS Estimate Next Quarter	-1.01

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Axsome Therapeutics, Inc.	11.49%	-4.3%	12.83%	66.02%	210.51%
Moderna, Inc.	-1.67%	18.26%	-0.21%	-64.15%	752.69%
Regeneron Pharmaceuticals, Inc.	-0.46%	13.21%	45.59%	84.19%	244.2%
Novo Nordisk A/s	-11.0%	18.31%	61.56%	186.46%	423.59%
Vertex Pharmaceuticals Incorporated	3.85%	14.43%	39.88%	147.45%	195.07%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Axsome Therapeutics, Inc.	NA	NA	0.0	-4.75	-2.32	-0.33	NA	3.04
Moderna, Inc.	24.73	NA	0.0	-7.19	-0.38	-0.16	NA	33.47
Regeneron Pharmaceuticals, Inc.	31.35	31.35	1.46	44.44	0.15	0.08	NA	250.15
Novo Nordisk A/s	44.28	44.28	2.36	3.43	1.0	0.25	0.01	22.18
Vertex Pharmaceuticals Incorporated	31.85	31.85	0.53	16.98	0.24	0.13	NA	71.8

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Axsome Therapeutics, Inc.	Buy	$4.1B	210.51%	NA	-118.07%
Moderna, Inc.	Buy	$45.3B	752.69%	24.73	-115.82%
Regeneron Pharmaceuticals, Inc.	Buy	$116.9B	244.2%	31.35	29.45%
Novo Nordisk A/s	Buy	$572.0B	423.59%	44.28	36.55%
Vertex Pharmaceuticals Incorporated	Buy	$126.7B	195.07%	31.85	39.46%

Organization	Axsome Therapeutics, Inc.
Employees	569
CEO	Dr. Herriot Tabuteau M.D.
Industry	Health Technology